Beta Bionics, Inc. (BBNX)
Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes.
$13.45-0.06%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-18.0%
The outlook
Beta Bionics, Inc. currently reads as neutral based on buy — 1.6 avg of 11 analysts, below its 50- & 200-day averages, 19% of the way from its 52-week low to high, avg target +49% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusBuy — 1.6 avg of 11 analysts
Price trendBelow its 50- & 200-day averages
52-week range19% of the way from its 52-week low to high
Price targetAvg target +49% vs current price
Analyst price target
~12-month · 11 analysts$20.08average target+49.3% vs now
Now $13.45
Low $14.00High $30.40
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$605.1M
52-wk high
$32.71
52-wk low
$8.80
50-day avg
$14.72
200-day avg
$17.61
Trailing P/E
—